The server is under maintenance between 08:00 to 12:00 (GMT+08:00), and please visit later.
We apologize for any inconvenience caused
Login  | Sign Up  |  Oriprobe Inc. Feed
China/Asia On Demand
Journal Articles
Laws/Policies/Regulations
Companies/Products
Studies on the actions of Xiefei Dingchuan injection(泻肺定喘注射液) on Ca2+Mg2+ATPase and Na+K+ATPase of red blood cell membrane in rats with pulmonary hypertension induced by monocrotaline
Author(s): 
Pages: 3-5
Year: Issue:  1
Journal: CHINESE JOURNAL OF INTEGRATED TRADITIONAL AND WESTERN MEDICINE IN INTENSIVE AND CRITICAL CARE

Keyword:  野百合碱肺动脉高压孔雀绿比色法Ca2+Mg2+ATP酶Na+K+ATP酶泻肺定喘注射液中医药;
Abstract: To investigate the mechanism of Xiefei Dingchuan injection (XFDCI,泻肺定喘注射液) in treating pulmonary hypertension by means of measuring the activity of Ca2+Mg2+ ATPase and Na+K+ATPase of red blood cell(RBC) membrane.Methods:The pulmonary hypertension models induced by monocrotaline in 18 rats were established then treated with XFDCI.Using cardiac catheter and chromatometry respectively the pulmonary artery pressure (PAP) and the activities of Ca2+Mg2+ATPase and Na+K+ATPase of RBC membrane were measured.Results:The activities of Ca2+Mg2+ATPase and Na+K+ATPase of RBC membrane in XFDCI group were obviously higher than those in pulmonary hypertension group.Conclusions:XFDCI is able to reduce the pulmonary hypertension and its mechanisms may be related to increasing the activities of Ca2+Mg2+ATPase and Na+K+ATPase of RBC membrane.
Related Articles
loading...